Eam Investors, LLC Iovance Biotherapeutics, Inc. Transaction History

Eam Investors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $1.62 Million - $3.73 Million	213,336 New	213,336 $3.16 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $1.47 Million - $1.93 Million	-53,143 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$27.21 - $41.0 $506,895 - $763,789	-18,629 Reduced 25.96%	53,143 $1.46 Million
Q1 2020 May 13, 2020	BUY	$19.54 - $38.85 $311,584 - $619,502	15,946 Added 28.56%	71,772 $2.15 Million
Q4 2019 Feb 11, 2020	BUY	$17.95 - $29.41 $46,023 - $75,407	2,564 Added 4.81%	55,826 $1.55 Million
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $422,351 - $610,402	-23,477 Reduced 30.59%	53,262 $969,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $750,507 - $1.88 Million	76,739 New	76,739 $1.88 Million
Q2 2018 Aug 03, 2018	SELL	$12.45 - $16.95 $2.78 Million - $3.78 Million	-223,029 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $1.81 Million - $4.35 Million	223,029 New	223,029 $3.77 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.